Stock AnalizBalchem Corp. BCPC
Major Chemicals · data as of November 13, 2026
Balchem Corp. (BCPC) is a industrial company listed in the US with a market value of about $5.5B. In the twelve months to September 30, 2026 it had revenue of $1.1B and net income of $171M, a net margin of 15.4%.
Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is financial health (5/5); the weakest is value (0/5).
Key numbers: a P/E of 32.6, a price to free cash flow of 30.9, 5-year revenue growth of 8% a year, a 5-year average ROIC of 12%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 53% below the current price.
Score: 2.6 / 5
Checks passed
- Profit margin improving
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
- Profitable 5 years in a row
- More cash than debt, or low debt to equity
- Positive free cash flow
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.0B | $954M | $922M | $942M | $799M | $704M | $644M | $644M | $595M | $553M |
| Net income | $171M | $155M | $128M | $109M | $105M | $96M | $85M | $80M | $79M | $90M | $56M |
| Free cash flow | $178M | — | — | — | $89M | $124M | $118M | $99M | $100M | $83M | $85M |
| EPS (diluted) | $5.31 | $4.75 | $3.93 | $3.35 | $3.25 | $2.94 | $2.60 | $2.45 | $2.42 | $2.79 | $1.75 |
| Net margin | 15.4% | 14.9% | 13.5% | 11.8% | 11.2% | 12.0% | 12.0% | 12.4% | 12.2% | 15.1% | 10.1% |
| ROIC | — | 12.6% | 11.9% | 11.6% | 11.6% | 10.9% | 10.5% | 11.1% | 10.0% | 11.7% | 7.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 4 analysts is $213.50, 23% above the current price; targets range from $175.00 to $254.00; the consensus rating is “Buy”; expected EPS is $5.87 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Balchem’s P/E ratio?
About 32.6, based on the last twelve months of diluted earnings per share (forward P/E about 28.3).
Is Balchem stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 53% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Balchem pay a dividend?
Yes. The dividend yield is about 0.55%, and it has paid dividends for 10 years in our data.
Is Balchem a good stock to buy?
We do not give buy or sell advice. Balchem scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.